| Product Name | PHA-543613 |
|---|---|
| CAS | 478149-53-0 |
| Formula | C15H17N3O2 |
| MW | 271.31 |
| Appearance | White to off-white powder |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 5 mg | 3-5days | ¥600.00 | Visible after login | |
| 10 mg | 3-5days | ¥900.00 | Visible after login | |
| 25 mg | 3-5days | ¥1660.00 | Visible after login |
| Product Name | PHA-543613 |
|---|---|
| CAS | 478149-53-0 |
| Formula | C15H17N3O2 |
| MW | 271.31 |
| Appearance | White to off-white powder |
PHA-543613 is a potent, orally bioactive, BBB (blood-brain barrier)-crossing, and selective α7 nAChR agonist with Ki of 8.8 nM. PHA-543613 is more selective for α7-nAChR than α3β4, α1β1γδ, α4β2 and 5-HT3 receptors. PHA-543613 may be used to study cognitive deficits in Alzheimer's disease (AD) and schizophrenia.